2011至2020年美国长期透析或肾移植患者的阿片类药物处方趋势
该研究分析美国肾脏数据系统2011至2020年数据,发现终末期肾病患者接受至少一种或长期阿片类药物处方的比例分别从60%降至42%、从23%降至13%(趋势P<0.001)。透析和肾移植患者中,短期和长期阿片处方均与更高全因死亡风险相关,且死亡风险随吗啡毫克当量单调增加。
要点
- 终末期肾病患者阿片处方率在2011至2020年间显著下降。
- 短期和长期阿片处方均与透析及肾移植患者更高死亡风险相关。
- 长期阿片处方的死亡风险随吗啡毫克当量增加而单调升高。
核心结论
- 终末期肾病患者阿片类药物处方率在2011至2020年间下降。
- 短期和长期阿片处方均与透析和肾移植患者更高死亡风险相关。
- 长期阿片处方的死亡风险随吗啡毫克当量单调增加。
研究设计与样本
- 分析美国肾脏数据系统2011至2020年数据库,描述终末期肾病患者阿片处方趋势。
- 检查长期阿片处方相关因素,并评估短期或长期阿片处方与全因死亡的关联。
主要发现
- 接受至少一种阿片处方的患者比例从60%降至42%(趋势P<0.001)。
- 接受长期阿片处方的患者比例从23%降至13%(趋势P<0.001)。
- 氢可酮和羟考酮处方率下降幅度最大。
- 女性、贫困者和农村地区患者更可能接受长期阿片处方。
- 白人患者和45–64岁患者处方率最高。
临床怎么用
- 透析和肾移植患者使用阿片类药物时需警惕短期和长期处方相关的死亡风险。
- 长期阿片处方应关注吗啡毫克当量,因其与死亡风险单调相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: The rate of prescription of opioid medication decreased between 2011 and 2020 for patients with ESRD. The risk of death for dialysis and kidney transplant patients increased as morphine milligram equivalents in prescriptions increased. BACKGROUND: Pain is important for patients with kidney failure, but opioid medication prescriptions are associated with morbidity and mortality. The Centers for Disease Control and Prevention issued opioid prescription guidelines in 2016 and 2022, associated with dramatically decreased prescription rates in the United States. It is critical to know whether nationwide opioid prescription rates for patients with kidney failure have decreased. METHODS: We analyzed the United States Renal Data System database from 2011 to 2020 to describe trends in the proportion of patients with ESKD who received one or more, or long-term, opioid prescriptions, examined factors associated with long-term opioid prescriptions, and evaluated associations of all-cause death with short-term or long-term opioid prescriptions. RESULTS: From 2011 to 2022, the percentage of patients with kidney failure (dialysis and kidney transplant) who received at least one or more, or who had received long-term, opioid medication prescriptions decreased steadily, from 60% to 42%, and from 23% to 13%, respectively (both P for trend < 0.001). The largest reductions in prescription rates were for hydrocodone and oxycodone. Similar trends existed for dialysis and kidney transplant patients. Women, the poor, and those in rural settings were more likely to receive long-term opioid prescriptions. Prescription rates were highest in White patients and those aged 45–64 years. Short-term and long-term opioid medication prescriptions were associated with higher mortality in both dialysis and kidney transplant patients. CONCLUSIONS: The opioid prescription rates of patients with ESKD decreased between 2011 and 2020. Higher mortality risk was associated with both short-term and long-term opioid prescriptions. Mortality risk was monotonically associated with morphine milligram equivalents in patients with kidney failure who received long-term opioid prescriptions.
引用
- Kimmel PL, Fwu CW, Nolin TD, et al. Opioid Prescriptions for US Patients Undergoing Long-Term Dialysis or with Kidney Transplant from 2011 to 2020. J Am Soc Nephrol. 2024. PMID: 39226330. doi:10.1681/ASN.0000000000000478
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。